David W Kimberlin, MD
Disclosures: Nothing to disclose
Since joining the faculty at The University of Alabama at Birmingham in 1996, Dr

Dr. David Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book), and was Editor of the 2015 edition and Associate Editor for the 2009 and 2012 editions.  He also will serve as Editor for the 2021 edition.  Dr. Kimberlin served as a member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID) from 2005-2011, and is the AAP Red Book liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP).  At the University of Alabama at Birmingham, Dr. Kimberlin is Vice Chair for Clinical and Translational Research and Co-Director of the Division of Pediatric Infectious Diseases.  His research focuses on antiviral therapies in neonates and infants for rare diseases such as neonatal herpes and congenital CMV, and more common diseases such as those caused by influenza and enteroviruses.